Trimi vs Willow
$125/mo against $399/mo for tirzepatide. Which is worth it, and for whom.
Updated 2026-09-18
Both sell tirzepatide. Trimi costs $125 a month and Willow costs $399, a difference of $274 a month or about $3,288 a year. The desk reads it as follows.
Trimi is lowest flat price with named pharmacies. Willow is straightforward single-price plans. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.
Advert against bill. Trimi advertises $125 and bills $125; Willow advertises $399 and bills $399. Both gaps are the same size, so the advertised comparison happens to hold.
Side by side
| Trimi | Willow | |
|---|---|---|
| Advertised | $125 | $399 |
| Billed | $125 | $399 |
| Gap | none | none |
| Per year, billed | $1,500 | $4,788 |
Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.
The split
3 differences on the record. The others match.
| Trimi | Willow | |
|---|---|---|
| Price is the same at every dose | Yes | No |
| Month-to-month without prepaying a block | No | Yes |
| Names the compounding pharmacy publicly | Yes | No |
What each puts on the record: Trimi
- One flat charge covers medication, clinician visits, check-ins and free overnight shipping; no separate membership.
- Names its compounding pharmacies publicly: VialsRx (Texas Board of Pharmacy #35264) and GreenwichRx, with a certificate of analysis available on request.
Where it wins: The cheapest verified flat rate for compounded tirzepatide in this comparison. Watch for: Both headline prices are annual-plan rates. Confirm the month-to-month figure and the refund terms before prepaying twelve months.
What each puts on the record: Willow
Where it wins: A single price with no membership arithmetic. Watch for: There is little published detail on how dose changes are handled. Ask before committing.
In each one’s favour
Trimi.
- The cheapest verified flat rate for compounded tirzepatide in this comparison.
- Names its pharmacies with a licence number and offers a certificate of analysis — almost nobody else in this market does.
Willow.
- A single price with no membership arithmetic.
Trimi scores higher overall at 4.6 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.
The desk’s call
The board says Trimi. What the board cannot say is whether the advertised figures you were shown elsewhere match these — check the gap row, because a listing that advertises low and bills high will beat an honest one in any comparison built on advertised prices.
The verdict
On the board, Trimi at $125 a month is the more defensible choice on arithmetic alone. Willow earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Trimi and Willow.
How they sit against everyone else
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
More from the desk
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.
- Willow tirzepatide review
Advertised at $399 and billed at $399 — no gap. Position 15 of 18 on our board.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- The twelve-month cost
Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure
